386 filings
Page 3 of 20
6-K
GMAB
Genmab
23 Jan 24
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2023
9:04am
6-K
GMAB
Genmab
22 Jan 24
Genmab Announces Decision in Arbitration Appeal under License Agreement with Janssen
8:01pm
6-K
GMAB
Genmab
3 Jan 24
Current report (foreign)
8:35am
6-K
GMAB
Genmab
13 Dec 23
Current report (foreign)
11:46am
6-K
GMAB
Genmab
5 Dec 23
Capital Increase in Genmab as a Result of Employee Warrant Exercise
6:06pm
6-K
GMAB
Genmab
1 Dec 23
Current report (foreign)
1:15pm
6-K
GMAB
Genmab
21 Nov 23
Current report (foreign)
4:51pm
6-K
GMAB
Genmab
9 Nov 23
Major Shareholder Announcement
10:15am
6-K
GMAB
Genmab
8 Nov 23
Major Shareholder Announcement
12:24pm
6-K
GMAB
Genmab
7 Nov 23
Genmab Announces Financial Results for the First Nine Months of 2023
11:12am
6-K
GMAB
Genmab
17 Oct 23
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2023
8:22am
6-K
GMAB
Genmab
5 Oct 23
Current report (foreign)
10:35am
6-K
GMAB
Genmab
28 Sep 23
Current report (foreign)
4:15pm
6-K
GMAB
Genmab
25 Sep 23
Current report (foreign)
8:53am
6-K
GMAB
Genmab
13 Sep 23
Current report (foreign)
9:59am
6-K
GMAB
Genmab
12 Sep 23
Capital Increase in Genmab as a Result of Employee Warrant Exercise
3:05pm
6-K
GMAB
Genmab
5 Sep 23
Current report (foreign)
9:12am
6-K
GMAB
Genmab
16 Aug 23
Current report (foreign)
1:44pm
6-K
GMAB
Genmab
15 Aug 23
Current report (foreign)
3:06pm
6-K
GMAB
Genmab
3 Aug 23
Genmab Announces Financial Results for the First Half of 2023
11:16am